Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

China flag China · Delayed Price · Currency is CNY
25.26
+0.34 (1.36%)
Mar 6, 2026, 4:00 PM EST
-9.07%
Market Cap 10.40B
Revenue (ttm) 1.39B
Net Income (ttm) 137.62M
Shares Out 411.25M
EPS (ttm) 0.33
PE Ratio 76.67
Forward PE n/a
Dividend 0.80 (3.17%)
Ex-Dividend Date Jun 10, 2025
Volume 1,434,890
Average Volume 1,890,283
Open 24.94
Previous Close 24.92
Day's Range 24.92 - 25.35
52-Week Range 23.80 - 29.63
Beta 0.65
RSI 39.20
Earnings Date Apr 21, 2026

About SHA:688739

Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use worldwide. It offers inactivated Japanese encephalitis vaccine (IJEV) and SPEEDA-rabies vaccine. The company’s rabies and influenza vaccines are in the new drug application stage; haemophilus influenzae type b vaccine in phase III; recombinant human papillomavirus 15-valent vaccine is in phase II; and 13-valent pneumococcal polysaccharide conjugate and varicella, as well as the live meningococ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 1,788
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688739
Full Company Profile

Financial Performance

In 2025, SHA:688739's revenue was 1.39 billion, a decrease of -17.06% compared to the previous year's 1.68 billion. Earnings were 137.62 million, a decrease of -59.86%.

Financial Statements

News

There is no news available yet.